[HTML][HTML] Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

LTJ Hickson, LGPL Prata, SA Bobart, TK Evans… - …, 2019 - thelancet.com
Background Senescent cells, which can release factors that cause inflammation and
dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with …

[HTML][HTML] Strategies for late phase preclinical and early clinical trials of senolytics

EOW Gerdes, A Misra, JME Netto, T Tchkonia… - Mechanisms of ageing …, 2021 - Elsevier
Cellular senescence and the hallmarks of aging contribute to age-related disease and
dysfunction. The Unitary Theory of Fundamental Aging Mechanisms highlights the …

Cellular senescence in idiopathic pulmonary fibrosis

DL Kellogg 3rd, DL Kellogg Jr, N Musi… - Current Molecular …, 2021 - Springer
Cellular senescence (CS) is increasingly implicated in the etiology of age-related diseases.
While CS can facilitate physiological processes such as tissue repair and wound healing …

Senolytic drugs: from discovery to translation

JL Kirkland, T Tchkonia - Journal of internal medicine, 2020 - Wiley Online Library
Senolytics are a class of drugs that selectively clear senescent cells (SC). The first senolytic
drugs Dasatinib, Quercetin, Fisetin and Navitoclax were discovered using a hypothesis …

Senolytics improve physical function and increase lifespan in old age

M Xu, T Pirtskhalava, JN Farr, BM Weigand… - Nature medicine, 2018 - nature.com
Physical function declines in old age, portending disability, increased health expenditures,
and mortality. Cellular senescence, leading to tissue dysfunction, may contribute to these …

Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age

MT Islam, E Tuday, S Allen, J Kim, DW Trott… - Aging …, 2023 - Wiley Online Library
Aging results in an elevated burden of senescent cells, senescence‐associated secretory
phenotype (SASP), and tissue infiltration of immune cells contributing to chronic low‐grade …

First evidence that senolytics are effective at decreasing senescent cells in humans

GM Ellison-Hughes - EBioMedicine, 2020 - thelancet.com
The increasing life expectancy of the world population has become an economic and global
public health problem. Increased life expectancy tracks with a higher incidence of multiple …

Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study

JN Justice, AM Nambiar, T Tchkonia, NK LeBrasseur… - …, 2019 - thelancet.com
Background Cellular senescence is a key mechanism that drives age-related diseases, but
has yet to be targeted therapeutically in humans. Idiopathic pulmonary fibrosis (IPF) is a …

The Achilles' heel of senescent cells: from transcriptome to senolytic drugs

YI Zhu, T Tchkonia, T Pirtskhalava, AC Gower… - Aging cell, 2015 - Wiley Online Library
The healthspan of mice is enhanced by killing senescent cells using a transgenic suicide
gene. Achieving the same using small molecules would have a tremendous impact on …

Cellular senescence: the good, the bad and the unknown

W Huang, LTJ Hickson, A Eirin, JL Kirkland… - Nature Reviews …, 2022 - nature.com
Cellular senescence is a ubiquitous process with roles in tissue remodelling, including
wound repair and embryogenesis. However, prolonged senescence can be maladaptive …